Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients.

[1]  Mark I. McCarthy,et al.  Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies , 2008, PloS one.

[2]  H. Tamemoto,et al.  Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects. , 2008, Diabetes research and clinical practice.

[3]  T. Lehtimäki,et al.  The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes. , 2008, Clinical biochemistry.

[4]  H. Hashimoto,et al.  Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. , 2008, European heart journal.

[5]  L. Salazar,et al.  Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[6]  R. de Caterina,et al.  Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants , 2005, European journal of clinical investigation.

[7]  D. Pessayre,et al.  The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. , 2003, Pharmacogenetics.

[8]  Muin J Khoury,et al.  Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. , 2003, American journal of human genetics.

[9]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002, The New England journal of medicine.

[10]  P. Doevendans,et al.  The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide , 2002, Journal of hypertension.

[11]  K. Tokunaga,et al.  Association of eNOS Glu298Asp Polymorphism With End-Stage Renal Disease , 2002, Hypertension.

[12]  K. Kugiyama,et al.  Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. , 2002, Circulation.

[13]  G. Rouleau,et al.  A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. , 2001, American heart journal.

[14]  K. Channon,et al.  Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.

[15]  M. Aviram,et al.  Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. , 2000, Circulation.

[16]  G. Murrell,et al.  Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity , 2000, FEBS letters.

[17]  J. Moss,et al.  Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. West.  Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[19]  Y. Hayashi,et al.  Expression of NADH/NADPH oxidase p22phox in human coronary arteries. , 1999, Circulation.

[20]  R. Mulcahy,et al.  An Electrophile Responsive Element (EpRE) Regulates β-Naphthoflavone Induction of the Human γ-Glutamylcysteine Synthetase Regulatory Subunit Gene , 1998, The Journal of Biological Chemistry.

[21]  Moinova Hr,et al.  An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. , 1998 .

[22]  K. Kanazawa,et al.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.

[23]  M. Chiba,et al.  Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control , 1997, Neurology.

[24]  D. Douer,et al.  An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. , 1997, Blood.

[25]  Y. Mizuno,et al.  Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. , 1996, Biochemical and biophysical research communications.

[26]  M. Matzuk,et al.  Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[28]  C. Polanczyk,et al.  Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease. , 2010, Clinical biochemistry.

[29]  M. Akın,et al.  The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. , 2005, Thrombosis research.

[30]  K. Tokunaga,et al.  Association of eNOS Glu 298 Asp Polymorphism With End-Stage Renal Disease , 2002 .

[31]  W. Dupont,et al.  Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.